CAPR: FDA Reviews BLA
Capricor Therapeutics announces FDA advisory committee meeting to review BLA for Deramiocel for Duchenne Muscular Dystrophy treatment
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.